Medicenna Therapeutics Corp. Description Of Risk Free Interest Rate Share Options Granted
Medicenna Therapeutics Corp. (MDNAF) reported Description Of Risk Free Interest Rate Share Options Granted of 5.10% for the 12-month period ending 2023-03-31, per its 20-F filed 2023-06-27.
Discontinued › Notes
ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted · last filed 2023-06-27
| Period end | Description Of Risk Free Interest Rate Share Options Granted 12 month |
|---|---|
| 2023-03-31 | 5.10% 20-F · filed 2023-06-27 |
| 2022-03-31 | 1.00% 20-F · filed 2023-06-27 |
| 2021-03-31 | 1.00% 20-F · filed 2023-06-27 |
| 2020-03-31 | 1.50% 20-F · filed 2022-06-22 |